Source: European Medicines Agency (EU) Revision Year: 2022 Publisher: GlaxoSmithKline (Ireland) Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
AVAMYS 27.5 micrograms/spray, nasal spray suspension.
| Pharmaceutical Form |
|---|
|
Nasal spray, suspension. White suspension. |
Each spray actuation delivers 27.5 micrograms of fluticasone furoate.
Excipient with known effect: One actuation delivers 8.25 micrograms of benzalkonium chloride.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Fluticasone |
Fluticasone has anti-inflammatory and vasoconstrictive features. Fluticasone given by inhalation at recommended doses has a potent glucocorticoid anti-inflammatory action within the lungs, resulting in a reduction of both symptoms and exacerbations of asthma, with a lower incidence and severity of adverse effects than those observed when corticosteroids are administered systemically. |
|
| Fluticasone furoate |
Fluticasone furoate is a synthetic trifluorinated corticosteroid that possesses a very high affinity for the glucocorticoid receptor and has a potent anti-inflammatory action. |
| List of Excipients |
|---|
|
Glucose anhydrous |
14.2 ml Type I or Type III amber bottle (glass) fitted with a metering spray pump.
The medicinal product is available in three pack sizes: 1 bottle of 30, 60 or 120 sprays.
Not all pack sizes may be marketed.
GlaxoSmithKline (Ireland) Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
EU/1/07/434/001
EU/1/07/434/002
EU/1/07/434/003
Date of first authorisation: 11 January 2008
Date of latest renewal: 17 December 2012
| Drug | Countries | |
|---|---|---|
| AVAMYS | Austria, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Mexico, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
